Clinical Trial Update: A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating spectacles with aspherical lenslets versus 0.05% atropine for myopia control; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• 0.05% atropine (atropine)
• Spectacles with aspherical lenslets

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Myopia | Phase 3 | Status: NOT_YET_RECRUITING